No evidence of added benefit for most new drugs entering German healthcare system

Share this post

More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply